Zobrazeno 1 - 10
of 99
pro vyhledávání: '"James H. Flory"'
Autor:
Dazhi Liu, Michael A. Weintraub, Christine Garcia, Marcus D. Goncalves, Ann Elizabeth Sisk, Alissa Casas, James J. Harding, Stephen Harnicar, Alexander Drilon, Komal Jhaveri, James H. Flory
Publikováno v:
Cancer Medicine, Vol 11, Iss 8, Pp 1796-1804 (2022)
Abstract Purpose The phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT) pathway controls insulin sensitivity and glucose metabolism. Hyperglycemia is one of the most common on‐target adverse effects (AEs) of PI3K/AKT inhibitors. As several P
Externí odkaz:
https://doaj.org/article/6261ca0f91da4aafad9291fcc66547c9
Autor:
Chang Su, Yongkang Zhang, James H. Flory, Mark G. Weiner, Rainu Kaushal, Edward J. Schenck, Fei Wang
Publikováno v:
npj Digital Medicine, Vol 4, Iss 1, Pp 1-13 (2021)
Abstract The coronavirus disease 2019 (COVID-19) is heterogeneous and our understanding of the biological mechanisms of host response to the viral infection remains limited. Identification of meaningful clinical subphenotypes may benefit pathophysiol
Externí odkaz:
https://doaj.org/article/213f9521bb6142eebb7ea2c2c8bc56e2
Autor:
Charles E. Leonard, Colleen M. Brensinger, Ghadeer K. Dawwas, Rajat Deo, Warren B. Bilker, Samantha E. Soprano, Neil Dhopeshwarkar, James H. Flory, Zachary T. Bloomgarden, Joshua J. Gagne, Christina L. Aquilante, Stephen E. Kimmel, Sean Hennessy
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-11 (2020)
Abstract Background The low cost of thiazolidinediones makes them a potentially valuable therapeutic option for the > 300 million economically disadvantaged persons worldwide with type 2 diabetes mellitus. Differential selectivity of thiazolidinedion
Externí odkaz:
https://doaj.org/article/7be6dabc839f4bdbb7f63feb7e38ed6d
Autor:
Tahj Blow BS, Parker N. Hyde PhD, John N. Falcone MD, Aaron Neinstein MD, Neil Vasan MD, PhD, Ritika Chitkara MPAS, Maurice A. Hurd BA, Sagar Sardesai MBBS, Maryam B. Lustberg MD, MPH, James H. Flory MD, MSCE, Jeff S. Volek PhD, Marcus D. Goncalves MD, PhD
Publikováno v:
Integrative Cancer Therapies, Vol 20 (2021)
Alpelisib is a α-selective phosphatidylinositol 3-kinase (PI3K) inhibitor approved for treatment of postmenopausal women, and men, with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2–), PIK3CA-mutated, adv
Externí odkaz:
https://doaj.org/article/b81288c92b19435e8df3a6d05b91595f
Publikováno v:
British Journal of Surgery. 110:545-547
Autor:
JeaYoung Min, Will Simmons, Samprit Banerjee, Fei Wang, Nicholas Williams, Yongkang Zhang, April B. Reese, Alvin I. Mushlin, James H. Flory
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1402-1405
Autor:
Joel C, Cantor, Sujoy, Chakravarty, Jennifer, Farnham, Jose, Nova, Sana, Ahmad, James H, Flory
Publikováno v:
Medical Care. 60:481-487
Project ECHO (Extension for Community Healthcare Outcomes), a tele-mentoring program for health care providers, has been shown to improve provider-reported outcomes, but there is insufficient research on patient-level outcomes.To evaluate the impact
Publikováno v:
Diabetes Care
OBJECTIVE To assess the association of sodium–glucose cotransporter 2 (SGLT2) inhibitors with diabetic ketoacidosis compared with dipeptidyl peptidase 4 (DPP-4) inhibitors and sulfonylureas in patients with type 2 diabetes. RESEARCH DESIGN AND METH
Publikováno v:
Journal of General Internal Medicine. 37:3645-3652
The association between nonadherence to chronic medications and potentially preventable healthcare utilization and spending is largely unknown.To examine the associations of chronic medication nonadherence with potentially preventable utilization and